Literature DB >> 1561397

Ankylosing spondylitis is caused by Klebsiella. Evidence from immunogenetic, microbiologic, and serologic studies.

A Ebringer1.   

Abstract

Ankylosing spondylitis is a form of reactive arthritis following Klebsiella infection, usually occurring in an HLA-B27-positive individual. This conclusion is based on evidence obtained from several disciplines: immunogenetic studies show that there is molecular mimicry between HLA-B27 and Klebsiella; increased isolation of fecal Klebsiella has been reported in both Europe and North America; and finally, antibodies to Klebsiella have been demonstrated in ankylosing spondylitis patients in England and Finland. It is suggested that therapeutic trials should be set up with the aim of eliminating Klebsiella microbes, in an endeavor to test the validity of this theory.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1561397

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  16 in total

1.  Distribution of HLA-B27 and its alleles in patients with reactive arthritis and with ankylosing spondylitis in Tunisia.

Authors:  Mariam Siala; Nadia Mahfoudh; Radhouane Gdoura; Mohamed Younes; Hela Fourati; Arwa Kammoun; Ilhem Chour; Nihel Meddeb; Lilia Gaddour; Faiza Hakim; Sofien Baklouti; Naceur Bargaoui; Sleheddine Sellami; Adnene Hammami; Hafedh Makni
Journal:  Rheumatol Int       Date:  2009-01-20       Impact factor: 2.631

Review 2.  Stress proteins in the pathogenesis of spondyloarthritis.

Authors:  José Pablo Romero-López; María Lilia Domínguez-López; Rubén Burgos-Vargas; Ethel García-Latorre
Journal:  Rheumatol Int       Date:  2018-05-31       Impact factor: 2.631

Review 3.  Clinical, bacteriological, and serological aspects of Klebsiella infections and their spondylarthropathic sequelae.

Authors:  H Sahly; R Podschun
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

4.  Ig A antibodies to klebsiella in ankylosing spondylitis.

Authors:  O Ardiçoğlu; M B Atay; H Ataoğlu; N Etiz; H Ozenci
Journal:  Clin Rheumatol       Date:  1996-11       Impact factor: 2.980

5.  Enhanced jejunal production of antibodies to Klebsiella and other Enterobacteria in patients with ankylosing spondylitis and rheumatoid arthritis.

Authors:  O Mäki-Ikola; R Hällgren; L Kanerud; N Feltelius; L Knutsson; K Granfors
Journal:  Ann Rheum Dis       Date:  1997-07       Impact factor: 19.103

Review 6.  HLA-B27 associated spondyloarthropathy, an autoimmune disease based on crossreactivity between bacteria and HLA-B27?

Authors:  J H Ringrose
Journal:  Ann Rheum Dis       Date:  1999-10       Impact factor: 19.103

7.  Somatic serogroups, capsular types, and species of fecal Klebsiella in patients with ankylosing spondylitis.

Authors:  P Toivanen; D S Hansen; F Mestre; L Lehtonen; J Vaahtovuo; M Vehma; T Möttönen; R Saario; R Luukkainen; M Nissilä
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

Review 8.  The use of a low starch diet in the treatment of patients suffering from ankylosing spondylitis.

Authors:  A Ebringer; C Wilson
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

9.  Comparison of the antibody responses to the 77 Klebsiella capsular types in ankylosing spondylitis and various rheumatic diseases.

Authors:  H Sahly; J Kekow; R Podschun; M Schaff; W L Gross; U Ullmann
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

10.  Widespread scleredema accompanied with a monoclonal gammopathy in a patient with advanced ankylosing spondylitis.

Authors:  Hyun Kyu Chang; You Chan Kim; Bum Sun Kwon
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.